We could not find any results for:
Make sure your spelling is correct or try broadening your search.
L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - MSCL Canada NewsWire TORONTO, le 17 déc. 2024 TORONTO, le 17 déc. 2024 /CNW/...
Canadian Investment Regulatory Organization Trade Resumption - MSCL Canada NewsWire TORONTO, Dec. 17, 2024 TORONTO, Dec. 17, 2024 /CNW/ - Trading resumes in: Company: Satellos Bioscience...
Suspension de la négociation par l'Organisme canadien de réglementation des investissements - MSCL Canada NewsWire TORONTO, le 16 déc. 2024 TORONTO, le 16 déc. 2024 /CNW/...
Canadian Investment Regulatory Organization Trading Halt - MSCL Canada NewsWire TORONTO, Dec. 16, 2024 TORONTO, Dec. 16, 2024 /CNW/ - The following issues have been halted by CIRO: Company:...
- Marks successful completion of full enrollment of SAD cohorts and the first two MAD cohorts in the healthy volunteer study - Up to 10 adult participants with genetically confirmed Duchenne...
Satellos Bioscience Inc. (TSX:MSCL, OTCQB:MSCLF) (“Satellos”), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and...
Satellos Bioscience Inc. (TSX:MSCL, OTCQB:MSCLF) ("Satellos" or the "Company"), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle...
Satellos Bioscience Inc. (TSX: MSCL) (OTCQB: MSCLF) (“Satellos” or the “Company”), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle...
- Completed enrollment for SAT-3247 in Duchenne muscular dystrophy (DMD) in the first three (of five) single-ascending dose (SAD) cohorts with no safety concerns and initiated enrollment of first...
Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSX: MSCL) (OTCQB: MSCLF), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.05 | 6.02409638554 | 0.83 | 0.89 | 0.81 | 295370 | 0.8699015 | CS |
4 | 0.18 | 25.7142857143 | 0.7 | 1.32 | 0.69 | 254098 | 0.92672157 | CS |
12 | 0.39 | 79.5918367347 | 0.49 | 1.32 | 0.485 | 181863 | 0.8326116 | CS |
26 | 0.36 | 69.2307692308 | 0.52 | 1.32 | 0.45 | 111290 | 0.74695529 | CS |
52 | 0.26 | 41.935483871 | 0.62 | 1.32 | 0.38 | 92454 | 0.6858677 | CS |
156 | 0.26 | 41.935483871 | 0.62 | 1.32 | 0.38 | 92454 | 0.6858677 | CS |
260 | 0.26 | 41.935483871 | 0.62 | 1.32 | 0.38 | 92454 | 0.6858677 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions